晚期肝细胞癌的治疗选择:生物药物的潜力
Federico Rossari1,2, Silvia Foti1, Silvia Camera1
1Department of Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy.
新的生物治疗方法正在彻底改变晚期肝细胞癌 (HCC) 护理. 对基于免疫的疗法和组合策略的进一步研究对于改善患者的治疗结果和扩大治疗资格至关重要.
科学领域:
- 肝细胞癌 (HCC) 研究研究
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 先进的HCC是一个重大的全球健康挑战.
- 生物治疗最近改变了HCC的管理.
- 需要进一步创新治疗方案,特别是基于免疫的方法.
研究的目的:
- 综合审查正在发展的高级HCC的生物治疗方法.
- 检查这些干预措施的关键临床试验和临床前研究.
- 突出它们对HCC治疗模式的影响.
主要方法:
- 对免疫检查点抑制剂的审查.
- 对抗血管原和瘤向单克隆抗体的分析.
- 检查治疗性疫苗,瘤病毒,采用细胞疗法和基于细胞因子的疗法.
主要成果:
- 生物治疗正在重塑先进的HCC管理.
- 组合策略对最大限度地提高疗效和启用治愈方法充满希望.
- 预测性生物标志物对于优化患者选择和结果至关重要.
结论:
- 继续探索新的基于免疫的疗法和组合策略对于高级HCC至关重要.
- 通过生物标志物识别进行个性化医疗将增强治疗效益.
- 目标是增加有资格接受治愈治疗的患者数量.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
相关概念视频
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
